Biotricity (BTCY)
(Delayed Data from OTC)
$0.30 USD
+0.10 (50.00%)
Updated Oct 2, 2024 03:56 PM ET
3-Hold of 5 3
F Value B Growth C Momentum C VGM
Brokerage Reports
0 items in cart
Biotricity Inc. [BTCY]
Reports for Purchase
Showing records 1 - 11 ( 11 total )
Company: Biotricity Inc.
Industry: Medical Info Systems
Gross Margins Improve as December Posts Incremental Gains; Reit Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: Biotricity Inc.
Industry: Medical Info Systems
Perceptible Value Proposition Lost in Translation; Downgrade to Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: Biotricity Inc.
Industry: Medical Info Systems
Growth in Recurring Revenue and Device Sales Chart Path Toward Profitability; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: Biotricity Inc.
Industry: Medical Info Systems
Open Kamono Exposes Growing SaaS; Reverse Split Necessitates Altered Price Target; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: Biotricity Inc.
Industry: Medical Info Systems
December Call Highlighted Distribution Partnerships; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: Biotricity Inc.
Industry: Medical Info Systems
Company: Biotricity Inc.
Industry: Medical Info Systems
Early Synergies Between Bioflux and Biotres Expected Shortly; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: Biotricity Inc.
Industry: Medical Info Systems
Momentum Kicking Up But Market Valuations Are Tough-Resetting to a Lower Target; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: Biotricity Inc.
Industry: Medical Info Systems
Quarter Caps Pivotal Six Months-Institutions Take Notice; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: Biotricity Inc.
Industry: Medical Info Systems
We are initiating coverage with a Buy rating and setting a potentially conservative $6 price target
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: Biotricity Inc.
Industry: Unclassified
We initiate coverage on Biotricity, Inc. with a price target of $4.20
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A
|